![7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione](https://impurity.com/wp-content/uploads/2023/08/B740035.png){kind=small}
7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione
- Catalogue No.: IM033805
- CAS No.: 2253964-85-9
- Mol. Formula: C₂₅H₂₈N₈O₂
설명
| Catalogue Number | IM033805 |
| CAS No. | 2253964-85-9 |
| Chemical Name | 7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione |
| Molecular Formula | C₂₅H₂₈N₈O₂ |
| Molecular Weight | 472.54 |
| Appearance | Off-White to Light Beige Solid |
| Melting Point | >151°C (dec.) |
| Storage | -20°C, Hygroscopic |
| Solubility | Aqueous Acid (Slightly), DMSO (Slightly), Methanol (Slightly) |
| Applications | 7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione is an impurity of Linagliptin (L465900), a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. |
| Category | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
Note: All Products are stable to be shipped at room temperature, unless otherwise specified.
![5-[(6-O-Acetyl-β-D-galactopyranosyl)oxy]-7-hydroxy-4-(4-hydroxyphenyl)-2H-1-benzopyran-2-one](https://impurity.com/wp-content/uploads/2023/08/A178050.png)
English 
Korean
상품평
아직 상품평이 없습니다.